Monday, 2 May 2022

Reuters Global Healthcare: Amazon to reimburse U.S. employees who travel for abortions, other treatments

Amazon to reimburse U.S. employees who travel for abortions, other treatments

Amazon.com Inc , the second-largest U.S. private employer, told its staff on Monday it will pay up to $4,000 in travel expenses annually for non-life threatening medical treatments including abortions, according to a message seen by Reuters.

Purdue urges skeptical appeals court to revive Sackler opioid lawsuit shield

Judges on a U.S. appeals court appeared hesitant on Friday to revive a legal shield that would protect members of the Sackler family who own Purdue Pharma from lawsuits related to the prescription opioid OxyContin, a key to ending the company's bankruptcy.

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Moderna Inc's chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when it meets in June.

Planned Parenthood, other U.S. abortion rights groups to spend $150 mln on midterms

Three U.S. abortion rights advocacy groups will spend $150 million on the 2022 midterm elections, focusing on battleground states as they step up efforts to safeguard abortion access across the country, they said on Monday.

Philippines planning to give Myanmar 5 million Sputnik V vaccines

The Philippines is considering donating to Myanmar five million doses of Sputnik V COVID vaccine that are close to expiry, a senior health official said on Monday.

Poland has no 'rationale to invoke force majeure in Pfizer vaccine deal, EU official says

Poland has no "coherent rationale" to invoke force majeure in an existing contract in order to stop paying for more COVID-19 vaccines from Pfizer , a European Commission official told Reuters.

South Korea drops outdoor mask rule but many prefer to keep them on

South Korea has loosened rules requiring masks to be worn outdoors as COVID-19 cases drop, but many people are not taking them off yet due to pervasive Omicron infections.

U.S. FDA declines to approve third China-tested cancer therapy

The U.S. drug regulator has declined to approve a cancer drug tested mainly in China, the third rejection of a China-developed drug in a little over a month.

U.S. FDA declines to approve two more China-tested drugs

The U.S. Food & Drug Administration declined to approve two China-tested cancer treatments on Monday, saying one of the companies - Hutchmed Ltd - needs to test its drug for the U.S. population in a diverse multi-regional trial.

Bird flu puts organic chickens into lockdown from Pennsylvania to France

Organic and free-range chickens have been thrown into lockdown.

Related Videos

Moderna asks FDA to authorize COVID shot for kids

FDA pushes ahead to ban menthol cigarettes

Beijing ups COVID curbs, fears Shanghai-like misery

at